DV
Dividend Vision

HEPA — Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals Inc (HEPA)

Its deepest 1-year drawdown was 61.1%.

HEPA is a single-stock equity holding in Hepion Pharmaceuticals Inc, a pharmaceutical company. The fund provides direct exposure to a single biopharmaceutical issuer rather than a diversified portfolio, with no current dividend distributions or stated yield profile. This structure appeals primarily to investors seeking concentrated exposure to the company's pipeline and business development rather than those focused on regular dividend income.

HEPA key facts

Asset type
Stock
Asset class
Equity
Inception date
02/10/2014
Last close
$0.07
Market cap
$1,776,278
Average volume
59000.0
Payment date
06/03/2019
Beta
1.632
Payout ratio
0.0
P/E ratio
0.0508
Forward P/E
0.0
EPS
$1.20